These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36070939)

  • 21. Myelin oligodendrocyte glycoprotein (MOG) antibody-mediated disease: The difficulty of predicting relapses.
    Epstein SE; Levin S; Onomichi K; Langston C; Yeshokumar A; Fabian M; Sand IK; Klineova S; Lublin F; Dykstra K; Xia Z; De Jager P; Levine L; Farber R; Riley C; Vargas WS
    Mult Scler Relat Disord; 2021 Nov; 56():103229. PubMed ID: 34479112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination.
    Peschl P; Schanda K; Zeka B; Given K; Böhm D; Ruprecht K; Saiz A; Lutterotti A; Rostásy K; Höftberger R; Berger T; Macklin W; Lassmann H; Bradl M; Bennett JL; Reindl M
    J Neuroinflammation; 2017 Oct; 14(1):208. PubMed ID: 29070051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 'Leukodystrophy-like' phenotype in children with myelin oligodendrocyte glycoprotein antibody-associated disease.
    Hacohen Y; Rossor T; Mankad K; Chong W'; Lux A; Wassmer E; Lim M; Barkhof F; Ciccarelli O; Hemingway C
    Dev Med Child Neurol; 2018 Apr; 60(4):417-423. PubMed ID: 29288492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical features and management of coexisting anti-N-methyl-D-aspartate receptor encephalitis and myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis: a case report and review of the literature.
    Nan D; Zhang Y; Han J; Jin T
    Neurol Sci; 2021 Mar; 42(3):847-855. PubMed ID: 33409829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and MRI phenotype of children with MOG antibodies.
    Fernandez-Carbonell C; Vargas-Lowy D; Musallam A; Healy B; McLaughlin K; Wucherpfennig KW; Chitnis T
    Mult Scler; 2016 Feb; 22(2):174-84. PubMed ID: 26041801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spectrum of anti-myelin oligodendrocyte glycoprotein antibody (MOG-Ab)-associated diseases: an Indian perspective.
    Chaudhuri J; Biswas T; Ganguly G; Datta S; Pandit A; Biswas A
    Acta Neurol Belg; 2021 Aug; 121(4):927-931. PubMed ID: 32314270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late-onset acute disseminated encephalomyelitis followed by optic neuritis without anti-myelin oligodendrocyte glycoprotein antibodies: a biopsied case report.
    Mori M; Sakai K; Tada Y; Nozaki I; Usui Y; Ichinose T; Tanaka S; Takahashi T; Nakada M; Yamada M
    Neurol Sci; 2021 Nov; 42(11):4731-4735. PubMed ID: 34170431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overlapping autoimmune syndrome: A case of concomitant anti-NMDAR encephalitis and myelin oligodendrocyte glycoprotein (MOG) antibody disease.
    Pérez CA; Agyei P; Gogia B; Harrison R; Samudralwar R
    J Neuroimmunol; 2020 Feb; 339():577124. PubMed ID: 31837635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature.
    Jarius S; Bieber N; Haas J; Wildemann B
    J Neurol; 2022 Oct; 269(10):5198-5212. PubMed ID: 35737110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination.
    Tea F; Lopez JA; Ramanathan S; Merheb V; Lee FXZ; Zou A; Pilli D; Patrick E; van der Walt A; Monif M; Tantsis EM; Yiu EM; Vucic S; Henderson APD; Fok A; Fraser CL; Lechner-Scott J; Reddel SW; Broadley S; Barnett MH; Brown DA; Lunemann JD; Dale RC; Brilot F;
    Acta Neuropathol Commun; 2019 Sep; 7(1):145. PubMed ID: 31481127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myelin oligodendrocyte glycoprotein antibodies: How clinically useful are they?
    Reindl M; Jarius S; Rostasy K; Berger T
    Curr Opin Neurol; 2017 Jun; 30(3):295-301. PubMed ID: 28248700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myelin oligodendrocyte glycoprotein-IgG-positive, steroid-responsive combined central and peripheral demyelination with recurrent peripheral neuropathy.
    Nakamura T; Kaneko K; Watanabe G; Harashima S; Kawasaki E; Tsukita K; Takahashi T; Nakashima I; Misu T; Suzuki Y
    Neurol Sci; 2021 Mar; 42(3):1135-1138. PubMed ID: 33078247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of anti-myelin oligodendrocyte glycoprotein antibody-positive multiphasic disseminated encephalomyelitis showing significant recovery after immunoadsorption plasmapheresis].
    Ogawa S; Kakiuchi K; Hosokawa T; Kagitani M; Ishida S; Arawaka S
    Rinsho Shinkeigaku; 2023 Aug; 63(8):518-522. PubMed ID: 37518016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat.
    Adelmann M; Wood J; Benzel I; Fiori P; Lassmann H; Matthieu JM; Gardinier MV; Dornmair K; Linington C
    J Neuroimmunol; 1995 Dec; 63(1):17-27. PubMed ID: 8557821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Encephalitis is an important clinical component of myelin oligodendrocyte glycoprotein antibody associated demyelination: a single-center cohort study in Shanghai, China.
    Wang L; ZhangBao J; Zhou L; Zhang Y; Li H; Li Y; Huang Y; Wang M; Lu C; Lu J; Zhao C; Quan C
    Eur J Neurol; 2019 Jan; 26(1):168-174. PubMed ID: 30133068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency of myelin oligodendrocyte glycoprotein antibodies in pediatric onset multiple sclerosis.
    Solmaz I; Doran T; Yousefi M; Konuskan B; Oncel I; Vural A; Anlar B
    Mult Scler Relat Disord; 2022 Dec; 68():104097. PubMed ID: 35998500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myelin oligodendrocyte glycoprotein-antibody-associated disorder: a new inflammatory CNS demyelinating disorder.
    Netravathi M; Holla VV; Nalini A; Yadav R; Vengalil S; Oommen AT; Reshma SS; Kamble N; Thomas PT; Maya B; Pal PK; Mahadevan A
    J Neurol; 2021 Apr; 268(4):1419-1433. PubMed ID: 33188477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retrospective analysis of children with myelin oligodendrocyte glycoprotein antibody-related disorders.
    Konuskan B; Yildirim M; Gocmen R; Okur TD; Polat I; Kilic H; Saltik S; Ozturk Z; Gucuyener K; Altunbasak S; Celik T; Kose G; Yilmaz A; Komur M; Kayilioglu H; Anlar B
    Mult Scler Relat Disord; 2018 Nov; 26():1-7. PubMed ID: 30212767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-myelin oligodendrocyte glycoprotein antibody-positive acute disseminated encephalomyelitis mimicking limbic encephalitis: A case report.
    Uchigami H; Arai N; Sekiguchi M; Ogawa A; Yasuda T; Seto A; Takahashi T; Takeuchi S
    Mult Scler Relat Disord; 2020 Feb; 38():101500. PubMed ID: 31733424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Commentary: Sorting the wheat from the chaff: identifying demyelinating components of the myelin oligodendrocyte glycoprotein (MOG)-specific autoantibody repertoire.
    Mathey E; Breithaupt C; Schubart AS; Linington C
    Eur J Immunol; 2004 Aug; 34(8):2065-71. PubMed ID: 15259003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.